{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:22:29Z","timestamp":1793110949801,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K08285"],"award-info":[{"award-number":["21K08285"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.kint.2023.08.013","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T12:01:51Z","timestamp":1693224111000},"page":"943-955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["The nucleotide-sensing Toll-Like Receptor 9\/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathy"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6198-0856","authenticated-orcid":false,"given":"Mingfeng","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1901-2111","authenticated-orcid":false,"given":"Hitoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ogiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2818-5081","authenticated-orcid":false,"given":"Maiko","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Fukao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Nihei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Makita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2282-1322","authenticated-orcid":false,"given":"Koshi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2023.08.013_bib1","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.08.013_bib2","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.3390\/biomedicines10123027","article-title":"Mucosal immune system dysregulation in the pathogenesis of IgA nephropathy","volume":"10","author":"Kano","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.kint.2023.08.013_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8473-z","article-title":"Toll-like receptor pathways in autoimmune diseases","volume":"50","author":"Chen","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.kint.2023.08.013_bib4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.amjms.2020.10.003","article-title":"IgA nephropathy: an interesting autoimmune kidney disease","volume":"361","author":"Rajasekaran","year":"2021","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.kint.2023.08.013_bib5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.kint.2019.08.022","article-title":"TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy","volume":"97","author":"Makita","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.08.013_bib6","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1074\/jbc.M113.512277","article-title":"Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes","volume":"289","author":"Suzuki","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2023.08.013_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-065X.2011.01067.x","article-title":"Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease","volume":"244","author":"Rickert","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.kint.2023.08.013_bib8","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/ni829","article-title":"DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL","volume":"3","author":"Litinskiy","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.kint.2023.08.013_bib9","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1681\/ASN.2007121311","article-title":"Toll-like receptor 9 affects severity of IgA nephropathy","volume":"19","author":"Suzuki","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.08.013_bib10","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/ndt\/gfr403","article-title":"Tonsillar TLR9 expression and efficacy of tonsillectomy with steroid pulse therapy in IgA nephropathy patients","volume":"27","author":"Sato","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.08.013_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089707","article-title":"Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy","volume":"9","author":"Nakata","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2023.08.013_bib12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1681\/ASN.2016050496","article-title":"Toll-like receptor 9 stimulation induces aberrant expression of a proliferation-inducing ligand by tonsillar germinal center B cells in IgA nephropathy","volume":"28","author":"Muto","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.08.013_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136965","article-title":"TLR7 in B cells promotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy","volume":"5","author":"Zheng","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.kint.2023.08.013_bib14","doi-asserted-by":"crossref","first-page":"F509","DOI":"10.1152\/ajprenal.00453.2005","article-title":"Microbial nucleic acids pay a Toll in kidney disease","volume":"291","author":"Pawar","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2023.08.013_bib15","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1080\/0886022X.2021.2000875","article-title":"Hydroxychloroquine in IgA nephropathy: a systematic review","volume":"43","author":"Stefan","year":"2021","journal-title":"Ren Fail"},{"key":"10.1016\/j.kint.2023.08.013_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.kint.2023.08.013_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.semnephrol.2018.05.021","article-title":"Murine models of human IgA nephropathy","volume":"38","author":"Suzuki","year":"2018","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2023.08.013_bib18","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1681\/ASN.2004030219","article-title":"Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23","volume":"16","author":"Suzuki","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.08.013_bib19","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1681\/ASN.2011121160","article-title":"Development of a model of early-onset IgA nephropathy","volume":"23","author":"Okazaki","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.08.013_bib20","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.kint.2021.12.011","article-title":"Molecular insights into the early stage of glomerular injury in IgA nephropathy using single-cell RNA sequencing","volume":"101","author":"Zambrano","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.08.013_bib21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.kint.2021.04.026","article-title":"Nasal-associated lymphoid tissue is the major induction site for nephritogenic IgA in murine IgA nephropathy","volume":"100","author":"Kano","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.08.013_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1124\/mol.113.089821","article-title":"Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in\u00a0vivo","volume":"85","author":"Lamphier","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.kint.2023.08.013_bib23","doi-asserted-by":"crossref","first-page":"113619","DOI":"10.1016\/j.bcp.2019.08.021","article-title":"Renoprotective effects of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via suppressing NF-\u03baB signaling and NLRP3 inflammasome activation by exosomes in rats","volume":"169","author":"Bai","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.kint.2023.08.013_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ki.5002300","article-title":"Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells","volume":"72","author":"Suzuki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.08.013_bib25","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.ajpath.2012.06.038","article-title":"Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes","volume":"181","author":"Hashimoto","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2023.08.013_bib26","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.4049\/jimmunol.1300706","article-title":"Guanine modification of inhibitory oligonucleotides potentiates their suppressive function","volume":"191","author":"R\u00f6mmler","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2023.08.013_bib27","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.3390\/cells10092271","article-title":"Inhibition of cellular and animal inflammatory disease models by NF-\u03baB inhibitor DHMEQ","volume":"10","author":"Ma","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.kint.2023.08.013_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-065X.2011.01082.x","article-title":"\u03b1-Defensins in human innate immunity","volume":"245","author":"Lehrer","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.kint.2023.08.013_bib29","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2004-12-4894","article-title":"Vav proteins regulate peripheral B-cell survival","volume":"106","author":"Vigorito","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.kint.2023.08.013_bib30","doi-asserted-by":"crossref","first-page":"41082","DOI":"10.1074\/jbc.C000726200","article-title":"CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10\/CLAP and activates NF-kappaB","volume":"275","author":"Bertin","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2023.08.013_bib31","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028415","article-title":"Interleukin-6 family cytokines","volume":"10","author":"Rose-John","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.kint.2023.08.013_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006609","article-title":"GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway","volume":"13","author":"Kiryluk","year":"2017","journal-title":"PLoS Genet"},{"key":"10.1016\/j.kint.2023.08.013_bib33","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1681\/ASN.2016091043","article-title":"Galactosylation of IgA1 is associated with common variation in C1GALT1","volume":"28","author":"Gale","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.08.013_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12882-019-1675-5","article-title":"C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin A nephropathy","volume":"21","author":"Xing","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2023.08.013_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2796.2005.01558.x","article-title":"Peripheral B lymphocyte \u03b21,3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy","volume":"258","author":"Qin","year":"2005","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.kint.2023.08.013_bib36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.clim.2010.05.009","article-title":"Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy","volume":"136","author":"Inoue","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.kint.2023.08.013_bib37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s10157-021-02157-x","article-title":"Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in Japan","volume":"26","author":"Matsuzaki","year":"2022","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2023.08.013_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/qjmed\/hcac185","article-title":"New-onset IgA nephropathy following COVID-19 vaccination","volume":"116","author":"Ma","year":"2023","journal-title":"QJM"},{"key":"10.1016\/j.kint.2023.08.013_bib39","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3390\/vaccines9111252","article-title":"New-onset and relapsed kidney histopathology following COVID-19 vaccination: a systematic review","volume":"9","author":"Wu","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.kint.2023.08.013_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002710","article-title":"CD200 receptor controls sex-specific TLR7 responses to viral infection","volume":"8","author":"Karnam","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.kint.2023.08.013_bib41","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.immuni.2016.09.011","article-title":"Structural analysis reveals that toll-like receptor 7 is a dual receptor for guanosine and single-stranded RNA","volume":"45","author":"Zhang","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2023.08.013_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nsmb.2943","article-title":"Toll-like receptor 8 senses degradation products of single-stranded RNA","volume":"22","author":"Tanji","year":"2015","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.kint.2023.08.013_bib43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/vaccines9020147","article-title":"SARS-CoV-2 mRNA vaccines: immunological mechanism and beyond","volume":"9","author":"Bettini","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.kint.2023.08.013_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1189\/jlb.0711371","article-title":"TLR9 and TLR7 agonists mediate distinct type I IFN responses in humans and nonhuman primates in\u00a0vitro and in\u00a0vivo","volume":"91","author":"Puig","year":"2012","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.kint.2023.08.013_bib45","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.ekir.2017.07.002","article-title":"Inhibition of STAT3 signaling reduces IgA1 autoantigen production in IgA nephropathy","volume":"2","author":"Yamada","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2023.08.013_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2022.04.001","article-title":"IL-6 and its role in IgA nephropathy development","volume":"66","author":"Groza","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.kint.2023.08.013_bib47","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000505748","article-title":"Leukemia inhibitory factor signaling enhances production of galactose-deficient IgA1 in IgA nephropathy","volume":"6","author":"Yamada","year":"2020","journal-title":"Kidney Dis (Basel)"},{"key":"10.1016\/j.kint.2023.08.013_bib48","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/cid\/ciab707","article-title":"Intravenous injection of coronavirus disease 2019 (COVID-19) mRNA vaccine can induce acute myopericarditis in mouse model","volume":"74","author":"Li","year":"2022","journal-title":"Clin Infect. Dis"},{"key":"10.1016\/j.kint.2023.08.013_bib49","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41541-022-00511-y","article-title":"mRNA vaccines induce rapid antibody responses in mice","volume":"7","author":"Gebre","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.kint.2023.08.013_bib50","first-page":"64","article-title":"Reevaluation of the mucosa-bone marrow axis in IgA nephropathy with animal models","volume":"72","author":"Suzuki","year":"2011","journal-title":"Adv Otorhinolaryngol"},{"key":"10.1016\/j.kint.2023.08.013_bib51","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1681\/ASN.2021081086","article-title":"Galactose-deficient IgA1 B cells in the circulation of IgA nephropathy patients carry preferentially lambda light chains and mucosal homing receptors","volume":"33","author":"Zachova","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.08.013_bib52","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1038\/jid.2009.80","article-title":"Hydroxychloroquine modulates metabolic activity and proliferation and induces autophagic cell death of human dermal fibroblasts","volume":"129","author":"Ramser","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.kint.2023.08.013_bib53","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2567.2006.02392.x","article-title":"A\u00a0distinct toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation","volume":"118","author":"M\u00e5nsson","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.kint.2023.08.013_bib54","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2567.2009.03143.x","article-title":"Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production","volume":"128","author":"Dorner","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.kint.2023.08.013_bib55","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","article-title":"TLR7 gain-of-function genetic variation causes human lupus","volume":"605","author":"Brown","year":"2022","journal-title":"Nature"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823006099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823006099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:05:16Z","timestamp":1758762316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253823006099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0085253823006099"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2023.08.013","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The nucleotide-sensing Toll-Like Receptor 9\/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathy","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2023.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}